Browsing Tag
Lannett Company
2 posts
Aurobindo Pharma clears FTC hurdle for $250m Lannett acquisition
Aurobindo Pharma clears the FTC hurdle for its $250 million Lannett deal. Explore divestitures, US expansion, integration risks and stock outlook.
June 19, 2026
Lannett gets FDA nod for clinical trial of biosimilar insulin glargine
Lannett Company has been given clearance from the US Food and Drug Administration (FDA) to proceed with a…
January 22, 2022